Related Experiment Videos
[Gd-DOTA in musculoskeletal diseases]
J Hodler1, J Orellano, S Thurnher
1Departement Medizinische Radiologie, Universitätsspital Zürich.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|November 1, 1990
Summary
Gadolinium-DOTA (Gd-DOTA) enhanced T1-weighted MRI sequences improve visualization of musculoskeletal lesions and their borders. Non-enhanced T2-weighted images are better for assessing perifocal reactions, with both sequences being complementary for aggressive lesions.
Area of Science:
- Radiology
- Medical Imaging
- Musculoskeletal System
Background:
- Magnetic Resonance Imaging (MRI) is crucial for musculoskeletal pathology assessment.
- Gadolinium-based contrast agents enhance lesion conspicuity.
- Gd-DOTA is a novel paramagnetic contrast medium.
Purpose of the Study:
- To compare the diagnostic utility of Gd-DOTA enhanced T1-weighted MRI with non-enhanced T2-weighted MRI for musculoskeletal lesions.
- To evaluate the incidence of side effects associated with Gd-DOTA administration.
Main Methods:
- A study involving 42 consecutive cases of musculoskeletal pathology.
- Comparison of enhanced T1-weighted images (Gd-DOTA) and non-enhanced T2-weighted images.
- Assessment of lesion depiction, borders, and side effects.
Main Results:
- Enhanced T1-weighted images superiorly depicted lesion components and borders with surrounding tissues.
- Non-enhanced T2-weighted images better delineated perifocal reactions from normal tissue.
- Both sequences were complementary for aggressive lesions, particularly malignant tumors.
- Enhanced T1-weighted images offered limited additional value for benign lesions.
- Gd-DOTA exhibited an acceptable side effect profile with no severe reactions.
Conclusions:
- Gd-DOTA enhanced T1-weighted MRI is valuable for characterizing musculoskeletal lesions, especially aggressive ones.
- Combining enhanced T1 and non-enhanced T2 sequences provides comprehensive assessment.
- Gd-DOTA is a safe contrast agent for musculoskeletal MRI.